Sharing Experiences on company success with Samm Anderegg
Samm Anderegg is Chief Executive Officer at DocStation, a software platform that connects pharmacists and health plans to operate value-based care models.
Viewpoint Awarded $2M NCI Phase II SBIR to conduct Phase 1 clinical trial at Mayo Clinic
Viewpoint Molecular Targeting, Inc., a University of Iowa start-up pharmaceutical company that has developed novel therapy and companion diagnostics for cancer, announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant valued at $2 million from the National Cancer Institute (NCI) The award will support preclinical development and a Phase 1 clinical imaging trial of it’s VMT01 companion diagnostic in advance of therapeutic trials.
Viewpoint Awarded $300K NIH Phase I SBIR
Viewpoint Molecular Targeting, Inc. has been awarded a $300,000 Small Business Innovation Research (SBIR) Phase I Grant by the National Institutes of Health.
10,000 Small Businesses
Huge congratulations to Steve Davis of Bio::Neos as he was one of 36 small business owners to complete the Goldman Sachs 10,000 Small Business Program!!
University of Iowa prototyping hub aims to win hearts and minds - by 3D printing them
Advancements in medical technology soon could help Iowa surgeons visualize exactly what is wrong with a patient’s organ — before they make their first incision.
Oregon State University Includes Santos in Graduate Digital Human Modeling Course
IOWA CITY, Iowa - Following the successful introduction of its first digital human modeling (DHM) course in 2018, Oregon State University (OSU) conducted a successful pilot of a computational ergonomics design course for advanced degrees last year. Now, the School of Mechanical, Industrial and Manufacturing Engineering plans to introduce Santos technologies into Digital Human Modeling for Design.
SantosHuman Inc., U Ottawa, and U Waterloo Partner to Research Canadian Soldier Performance Tool
This year, SantosHuman Inc. will engage in research with the University of Ottawa and the University of Waterloo to develop and validate a tool to predict and optimize performance and minimize injury risk to Canadian Armed Forces (CAF) soldiers based on personal, operational, equipment and environmental factors.
Licensing deal positions KemPharm's Apadaz for launch
Coralville-based KemPharm this week announced it has entered into a license agreement with KVK Tech Inc. for U.S. commercial rights to its FDA-approved prodrug, Apadaz.
IDx, Topcon sign exclusive AI platform agreement
IDx, the Coralville company behind the first and only FDA-cleared autonomous AI diagnostic system, has announced a new agreement with Topcon, a leading ophthalmic device manufacturer, to scale delivery of AI diagnostic solutions in the U.S. market.
Pages
